Trial intelligence / Profile preview

Ropivacaine in Spinal Anesthesia for Lower Back Surgery

NCT05824338Phase 1Recruiting

Sponsor
Fraser Health
Start
Aug 2024
Primary completion
Jul 2025
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 1, randomised trial of ropivacaine in Anesthesia (3 arms), sponsored by Fraser Health. Primary endpoints: Acceptability of study procedures and intervention: eligibility and recruitment, Acceptability of study procedures and intervention: attrition and 1 more. Started Aug 2024; status: recruiting.

02

Drugs

ropivacaine
03

Conditions

Anesthesia

Beyond the preview

Go deeper on NCT05824338.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05824338.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call